1971 Convention on Psychotropic Substances

This article is general information, not legal advice. Laws change; check current rules with official sources or a lawyer.

What the treaty does

The Convention on Psychotropic Substances was adopted in Vienna on 21 February 1971 and entered into force on 16 August 1976.^[1] It was designed to fill a regulatory gap left by the 1961 Single Convention on Narcotic Drugs: the older treaty covered plant-derived drugs like opium, coca, and cannabis, but not the wave of synthetic psychoactives—LSD, mescaline, MDMA, amphetamines, barbiturates—that emerged in the 1960s and became subjects of recreational and clinical interest.^[2]

The treaty establishes four Schedules based on abuse potential and recognized therapeutic use.^[1] Schedule I lists substances with high abuse potential and minimal medical value (e.g. LSD, psilocybin, MDMA). Schedules II through IV impose progressively lighter controls, with Schedule IV containing widely prescribed medications like diazepam and alprazolam.^[1] Strong evidence

Parties agree to require licenses for manufacture, trade, and distribution; restrict use to medical and scientific purposes; submit statistics to the International Narcotics Control Board (INCB); and criminalize unauthorized acts under domestic law.^[1] Strong evidence The treaty includes no international court; enforcement is diplomatic.

How cannabis and THC are actually handled

This is where most popular summaries create confusion. The cannabis plant, cannabis resin, extracts, and tinctures are scheduled under the 1961 Single Convention, not the 1971 Convention.^[2]

What the 1971 Convention controls is tetrahydrocannabinol (THC) as a molecule:^[1]

• Schedule I: delta-8, delta-10, and most other THC isomers except delta-9
• Schedule II: Dronabinol (delta-9-THC) and its stereoisomers, used in pharmaceutical products like Marinol

Dronabinol (delta-9-THC) was moved from Schedule I to Schedule II following a 1991 decision by the Commission on Narcotic Drugs (CND) based on a World Health Organization (WHO) review that recognized its pharmaceutical applications. Strong evidence

In December 2020, the UN Commission on Narcotic Drugs voted on scheduling recommendations from the WHO on cannabis. The CND rejected the WHO recommendation to delete dronabinol and THC from the 1971 Convention, so THC remained scheduled under the 1971 treaty. The CND separately accepted removing cannabis flower/resin from Schedule IV of the 1961 Convention—a symbolic but substantive shift that recognized cannabis may have medical value, though it remains in Schedule I of that treaty.

Practical outcome: If a country wants to market an isolated THC product to the public, it must satisfy obligations under the 1971 Convention. If it wants to sell flower or resin, the 1961 Convention applies. CBD (cannabidiol), which produces no psychoactive effect under the treaties' definitions, is not scheduled under either convention. Strong evidence

How substances get scheduled or rescheduled

The treaty's Article 2 sets out the procedure. A party state or the World Health Organization can propose adding, moving, or deleting a substance. The WHO Expert Committee on Drug Dependence (ECDD) reviews pharmacology, abuse liability, and therapeutic potential, then issues a recommendation to the UN Commission on Narcotic Drugs (CND).^[1] Strong evidence

The CND, currently composed of 53 member states elected by the UN Economic and Social Council, makes the final scheduling decision.^[1] Unlike the 1961 Convention, WHO recommendations under the 1971 Convention are considered 'determinative as to medical and scientific matters,' which means the CND can only vote against a WHO recommendation based on 'economic, social, legal, administrative and other factors.'^[1] Strong evidence In practice, the CND has often adopted WHO recommendations, though the 2020 cannabis votes showed the CND can and does dissent on policy grounds.

The INCB monitors compliance, collects statistical data, and can recommend embargoes against non-compliant states.^[1] Enforcement relies on diplomatic pressure and reputational consequences rather than legal sanctions.

Flexibilities and tensions with national legalization

The treaty includes limited flexibility. Article 32 permits parties to enter reservations at the time of ratification. Several nations have reserved the right to permit traditional or ritualized use of peyote, ayahuasca, and psilocybin mushrooms in specific cultural contexts.^[1][3]

There is no comparable exemption for adult-use legalization of synthetic THC products or cannabis flower. Countries that have legalized cannabis for adult recreational use—Uruguay, Canada, several U.S. states, and Germany's 2024 reform—operate in deliberate tension with their treaty obligations.^[4] The International Narcotics Control Board has stated repeatedly that recreational legalization violates the 1961 and 1971 conventions; affected governments have responded variously that they remain within the treaty's 'spirit,' are seeking renegotiation, or consider the obligations less binding than domestic law.^[4] Strong evidence

Withdrawal from the 1971 Convention is possible under Article 29 with six months' notice, but no party has withdrawn to enable cannabis reform. This reflects the political cost of withdrawing from a major international drug control framework and the preference of reforming states to maintain participation while pushing for policy change from within.

Common misconceptions

'The 1971 Convention bans cannabis worldwide.' False. The 1961 Single Convention bears primary responsibility for cannabis plant scheduling. The 1971 Convention controls THC the molecule.^[1][2] Strong evidence

'CBD is internationally controlled.' False. The WHO concluded in 2018 that pure cannabidiol (CBD) is not subject to international control, and the CND confirmed this finding in 2020. Strong evidence

'The treaties require criminalizing personal use.' Partially false. Article 22 of the 1971 Convention requires that unauthorized acts be 'punishable offenses,' but it explicitly permits alternative approaches to conviction or punishment for personal-use amounts, and many parties have decriminalized possession without technical violation of the treaty.^[1][4] Strong evidence

'The 2020 UN vote legalized cannabis.' False. The CND voted to remove cannabis from Schedule IV of the 1961 Convention (the most restrictive category), acknowledging potential medical value. Cannabis remains in Schedule I of the 1961 treaty, and THC remains scheduled under the 1971 Convention. Strong evidence

Legal notice and status

This article is informational only and is not legal advice. Treaty obligations, domestic law, scheduling decisions, and enforcement priorities change. If you need to determine how the 1971 Convention applies to a specific substance, product, or jurisdiction—especially for research, pharmaceutical work, import/export, or clinical use—consult a qualified attorney licensed in your jurisdiction and review the current International Narcotics Control Board Green List.

Last verified: 31 October 2026. This article was checked against the UN treaty text, the 2020 Commission on Narcotic Drugs decisions, the WHO 2018 CBD review, and the INCB Green List (30th edition, August 2023).

Sources

How this page was made

Related

• 1961 Single Convention on Narcotic Drugs — The UN treaty that unified international drug control and shaped cannabis prohibition glob...
• UN Drug Treaties and Cannabis — Three UN treaties control cannabis globally; legalization exists despite treaty language f...